Perspectives on isolated systolic hypertension in elderly patients

Archives of Family Medicine

Volumn 9, Issue 4, 2000, Pages 319-323

  Vardan, S ^a   Mookherjee, S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CLONIDINE; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; ISOSORBIDE DINITRATE; ISRADIPINE; LABETALOL; LONG ACTING DRUG; METHYLDOPA; NITRATE; NITRENDIPINE; RENIN; RESERPINE; VERAPAMIL;

AGING; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; EXERCISE; FATIGUE; HEALTH HAZARD; HUMAN; LIFESTYLE; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PLASMA RENIN ACTIVITY; REVIEW; RISK FACTOR; SODIUM RESTRICTION; SYSTOLIC HYPERTENSION; TREATMENT PLANNING;

EID: 0033831148     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.9.4.319     Document Type: Review

References (70)

1. Systolic hypertension
2. Systolic hypertension among the elderly
3. Significance of left ventricular mass in isolated systolic hypertension of the elderly
4. Une orientation nouvelle de la sphygmomanometric: La pression minima etalon sphygmomanometrique
5. Clinical significance of high and low pulse pressure with special reference to cardiac load and overload
6. Effects of treatment on morbidity in hypertension, I: Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg
7. Effects of treatment on morbidity in hypertension, II: Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg
8. Five-year findings of the hypertension program, I: Reduction in mortality of persons with high blood pressure, including mild hypertension
9. Anti-hypertensive therapy in patients above age 60 years: Fourth interim report of the European Working Party on High Blood Pressure in Elderly Patients: EWPHE
10. Arterial hypertension and ischemic heart disease: A report
11. Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham study
12. Predicting risk of ischemic heart disease and cerebro-vascular disease from systolic and diastolic blood pressures
13. Blood pressure (systolic and diastolic) and risky fatal coronary heart disease
14. Correlation of pathophysiology and pharmacotherapy in primary hypertension
15. Systolic blood pressure, arterial rigidity and risk of stroke: The Framingham Heart Study
16. Role of blood pressure in the development of congestive heart failure: The Framingham Heart Study
17. BP as a detriment of cardiac left ventricular muscle mass
18. Predicting death from renal failure in primary hypertension
19. Individualized selection of antihypertensive drug therapy for older patients
20. The natural history of borderline isolated systolic hypertension
21. Simultaneous direct and indirect blood pressure measurements in man at rest and work
22. Pseudohypertension in the elderly
23. Systolic hypertension: Direct and indirect blood pressure measurements and implications of the difference in the diastolic blood pressure by the two methods
24. 'Pipe-stem' brachial arteries: A cause of pseudohypertension
25. Osler's maneuver and pseudohypertension
26. Isolated systolic hypertension in the elderly
27. Isolated systolic hypertension in the elderly: An epidemiologic review
28. Systolic hypertension: Hemodynamic mechanism and choice of antihypertensive treatment
29. Forearm arterial distensibility in systolic hypertension
30. Pulsatile versus steady component of blood pressure: A cross sectional analysis and a prospective analysis on cardiovascular mortality
31. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction
32. Measures of blood pressure and myocardial infarction in treated hypertensive patients
33. Systolic hypertension: Nonhomogeneous disease
34. Systolic hypertension in the elderly: Hemodynamic response to long-term thiazide diuretic therapy and its side effects
35. Relationship between cardiac output, stroke volume and intracardiac pressures at rest and running exercise in supine position and some anthropometric data in healthy old men
36. Hemodynamics in labile hypertension: A follow-up study
37. Effects of diuretic therapy in low-, normal- and high-renin isolated systolic hypertension
38. Systemic systolic hypertension in the elderly: Correlation of hemodynamics, plasma volume, renin, aldosterone, urinary metanephrines and response to thiazide therapy
39. Renin dependency of blood pressure in isolated systolic hypertension
40. Effect of posture on blood pressure in the elderly
41. Hazards in treatment of systolic hypertension
42. Hemodynamic response to orthostatic stress in the elderly with systemic systolic hypertension before and after long-term thiazide diuretic therapy
43. Baroreflex function during 45-degree passive head-up tilt before and after long-term thiazide therapy in the elderly with systolic systemic hypertension
44. Hormonal response to orthostasis in elderly people with systemic systolic hypertension
45. Amelioration of high blood pressure in the elderly
46. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
47. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
48. Impact of the treatment of isolated systolic hypertension on behavioral variables: Results from the Systolic Hypertension in the Elderly Program
49. Blood pressure monitoring outside the office for the evaluation of patients with resistant hypertension
50. The Sixth Report of Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
51. Therapeutic decision making in systolic hypertension
52. Efficacy and reduced metabolic side effects of a 15-mg chlorthalidone formulation in the treatment of mild hypertension: A multicenter study
53. Effect of one year of thiazide therapy in plasma volume, renin, aldosterone, lipids and urinary metanephrines in systolic hypertension of elderly patients
54. Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg
55. Systolic blood pressure response in three subgroups of hypertensives treated with sustained-release diltiazem
56. Sustained-release isradipine compared with spirapril in the treatment of elderly patients with isolated systolic hypertension
57. An effective approach for treating elderly patients with isolated systolic hypertension: Results of an Italian multicenter study with fosinopril
58. Medical Research Council trial of treatment of hypertension in older adults: Principal results
59. Treatment of isolated systolic hypertension with labetalol in the elderly
60. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic hypertension in the elderly
61. Clonidine hydrochloride: Reviewing of pharmacologic and clinical aspects
62. Exclusion bias and false relationship of reserpine and breast cancer
63. Depression following reserpine: A re-evaluation
64. Benefit and potential harm of lowering high blood pressure
65. Blood pressure in the very old
66. The relationship of plasma renin activity to clinic and ambulatory blood pressure in elderly people with isolated systolic hypertension
67. Hypertension in the population at large
68. Trends in systolic blood pressure, 24-hour sodium excretion, and mortality in the elderly in Belgium